Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

Hepatology. 2006 Feb;43(2):209-20. doi: 10.1002/hep.21051.
No abstract available

Publication types

  • Review

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm / adverse effects
  • Antineoplastic Agents / adverse effects*
  • DNA, Viral / analysis
  • Hepatitis B Core Antigens / analysis
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B virus / drug effects*
  • Hepatitis B, Chronic* / diagnosis
  • Hepatitis B, Chronic* / drug therapy
  • Hepatitis B, Chronic* / prevention & control
  • Humans
  • Lamivudine / therapeutic use
  • Recurrence
  • Risk Factors
  • Rituximab
  • Virus Activation / drug effects

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • DNA, Viral
  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens
  • Lamivudine
  • Alemtuzumab
  • Rituximab